Billionaire Philippe Laffont Has 20% of His Hedge Fund's $39 Billion Portfolio Invested in 3 Clever AI Stocks

Core Insights - Philippe Laffont's Coatue Management is heavily invested in technology trends, particularly in artificial intelligence (AI), with over $39 billion in U.S. equities, where more than 20% is concentrated in three key stocks [1][2] Group 1: Taiwan Semiconductor Manufacturing (TSMC) - TSMC holds 8.5% of Coatue's assets and is the largest contract chip manufacturer globally, with a market share of 72% in foundry spending as of Q3 [4] - The company forecasts a revenue growth of 38% for Q1 and 30% for the full year, driven by price increases and scaling of its 3-nanometer process [5][8] - TSMC plans to invest $52 billion to $56 billion in capital expenditures, a 32% year-over-year increase, to expand manufacturing capacity [7] - Long-term revenue growth is expected to compound at around 25% from 2025 to 2029, with average growth of 20% from 2027 to 2029 [8] - The stock is currently trading at 27 times forward earnings, suggesting it remains undervalued given the anticipated earnings growth [9] Group 2: Lam Research - Lam Research accounts for 6.1% of Coatue's assets and provides wafer fabrication equipment, particularly for logic and memory chips [10] - The company is set to benefit from increased capital expenditures from chip manufacturers, with expectations of a 23% increase in wafer fabrication equipment sales in 2026 [11] - Lam's services segment generated $2 billion last quarter, up from $1.75 billion the previous year, providing a stable revenue base [13] - The stock trades at a forward P/E ratio of 46, which is considered expensive given the recent surge in share price amid a memory chip shortage [14] Group 3: Applied Materials - Applied Materials represents 5.8% of Coatue's assets and is the largest provider of wafer fabrication equipment, competing with Lam Research [15][16] - The company is expected to achieve similar revenue growth as Lam Research, with a 20% growth outlook for equipment revenue in 2026 [18] - The stock is currently trading at 34 times forward earnings, which is expected to drop to 27 by 2027, indicating a fair price given its growth potential [19]